News & Media

Press release
Number of shares and votes in Medivir

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that the number of shares and votes in Medivir has changed...

Read more
Press release
New data on Simeprevir presented at the Conference of the Asian Pacific Association for the Study of the Liver

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that new clinical data for the once‐daily HCV protease inhibitor simeprevir...

Read more
Press release
Medivir Capital Markets Meeting on 26 March 2015

Stockholm, Sweden — Medivir AB (OMX: MVIR) today announces that a Capital Markets Meeting will be arranged for investors, analysts and...

Read more
Press release
New members of Medivir’s management group

Stockholm, Sweden — Medivir AB (OMX: MVIR) is, as previously announced, conducting a reorganisation of the company’s management group which will,...

Read more
Press release
Presentation of the result of Medivir’s voluntary redemption programme

Stockholm, Sweden — Medivir AB (OMX: MVIR) announces the result of Medivir’s voluntary redemption programme. The redemption programme comprised a total...

Read more
Press release
Financial Statement, January – December 2014

October to December 2014 (2013) Net turnover totalled SEK 377.0 million (SEK 147.1 m), SEK 220.1 million (SEK 10.5 m) of...

Read more
Press release
Medivir’s Nomination Committee proposes new Board of Directors ahead of 2015 AGM

Stockholm, Sweden — Medivir AB (OMX: MVIR) today announced the Nomination Committee’s proposal for a new Board of Directors that will...

Read more
Press release
Final terms for Medivir’s voluntary redemption programme

Stockholm, Sweden — Medivir AB (OMX: MVIR) announces that the board of directors now has set the final terms for Medivir’s...

Read more
Press release
Medivir’s CEO increases his shareholding in the company

Stockholm, Sweden — Medivir AB (OMX: MVIR) announces that the company’s CEO, Niklas Prager, has bought 23,600 class B shares in...

Read more
Press release
Medivir makes change within the management team

Stockholm, Sweden — Medivir AB (OMX: MVIR) announces a reorganization of the management team in order to streamline and increase operational...

Read more
Press release
OLYSIO® sales during the fourth quarter 2014

Stockholm, Sweden — Medivir AB (OMX: MVIR) announces that the global fourth quarter net sales of OLYSIO® (simeprevir) amounted to 321...

Read more